Form 4: Director Barbarosh Acquires Sabra Health Care REIT Stock

Director Craig A. Barbarosh acquired 8,310 restricted stock units of Sabra Health Care REIT, Inc. under the company's incentive plan.

Summary

• Craig A. Barbarosh, a Director at Sabra Health Care REIT, Inc., acquired 8,310 restricted stock units (RSUs) on June 17, 2026.
• These RSUs were granted under the Issuer's 2009 Performance Incentive Plan.
• The RSUs vest in equal monthly installments starting July 17, 2026, and concluding by June 17, 2027, or the day before the next annual stockholders' meeting.
• Following this transaction, Barbarosh beneficially owns 63,326 shares of common stock, including 8,310 unvested RSUs and 55,016 vested but deferred stock units.
• The filing also includes a Power of Attorney document authorizing individuals to act on behalf of reporting persons for SEC filings.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard executive compensation grant rather than a significant strategic or financial event.

Positives

• Director compensation through restricted stock units indicates alignment of management interests with shareholders.
• The grant of RSUs suggests confidence in the company's future performance, incentivizing long-term value creation.
• Vesting schedule promotes retention and continued service from key personnel.

Negatives

• The acquisition is a grant of restricted stock units, not an open market purchase, which may not reflect direct investment conviction.

Risks

• The vesting of RSUs is subject to continued employment and specific timelines, with potential forfeiture if conditions are not met.
• The deferral of payment for vested stock units introduces a risk related to the timing of actual cash realization for the executive.

Future Outlook

The restricted stock units granted to Director Barbarosh are set to vest in monthly installments starting July 17, 2026, and concluding by June 17, 2027, or the day before the next annual stockholders' meeting, indicating a forward-looking incentive structure.

Industry Context

StockSavvy.ai notes that the issuance of restricted stock units to directors is a common practice in the REIT industry to align executive compensation with long-term shareholder value and company performance.

Corporate Governance

Related Party Transactions

• The acquisition of restricted stock units by Director Craig A. Barbarosh is a related party transaction, as it involves compensation from the issuer to a director.

Stakeholder Impact

• Shareholders: The grant of RSUs aligns director incentives with long-term shareholder value, potentially leading to better corporate performance.
• Employees: The existence of a Performance Incentive Plan suggests a broader framework for employee compensation and motivation.
• Management: Director Barbarosh benefits from the RSU grant, which vests over time, encouraging continued service and commitment.

Next Steps

• Vesting of restricted stock units will occur monthly from July 17, 2026, through June 17, 2027 (or prior to the next annual meeting).
• Payment of deferred stock units will occur according to prior agreements.

Key Dates

Keywords

Form 4, SEC Filing, Sabra Health Care REIT, SBRA, Director, Restricted Stock Units, Stock Acquisition, Insider Trading, Executive Compensation, Beneficial Ownership